Zhejiang Hisun Sulikang Biotechnology

Zhejiang Hisun Sulikang Biotechnology Co., Ltd. is a producer of special medical and functional foods for individuals with digestive disorders, metabolic challenges, or other special disease states. The company was established in October 2015 as a wholly-owned subsidiary of the A-share listed company Zhejiang Hisun Pharmaceutical, which was founded in 1956. Hisun Sulikang was created to extend the parent company's reach into the health industry, leveraging its research and development teams and production capabilities.

The company's product line focuses on foods for special medical purposes (FSMPs), health supplements, and functional foods, available in forms like solid and liquid beverages, tablets, and freeze-dried products. One of its key achievements was the development of Yinengjia®, a protein component formula for special medical purposes, which received the first domestic registration certificate for a protein component FSMP from the State Administration for Market Regulation. The firm operates an 8,000-square-meter GMP-standardized factory with 16 production lines, including advanced automated and specialized medical food production lines.

Hisun Sulikang has secured multiple rounds of funding to support its growth. In July 2023, the company completed a financing round of over 100 million RMB from investors including Bell Capital, Yuanquan Industrial, and the team of Yang Jiyong, who serves as the company's General Manager. This was followed by another round in April 2024 for tens of millions of RMB. The company's business model is centered on the research, production, and sale of its specialized food products, serving a market that requires specially processed and formulated nutrition.

Keywords: medical foods, functional foods, digestive disorders, metabolic disorders, foods for special medical purposes, FSMP, clinical nutrition, health supplements, pharmaceutical, biotechnology, nutritional therapy, protein components, Yinengjia, GMP manufacturing